1Georgieva J,Sinha P,Schadendorf D,et al.Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesion[J].Clin Pathol,2001,54(3):229-335.
3Resnitzki D,Gossen M,Bujard H,et al.Acceleration of the G1/S phase transition by cyclinD1 and E with an inducible system[J].Mol Cell Biol,1994,14(3):1669-1679.
4Surendra P,Lipman J,Goldman H,et al.Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma[J].Cancer Res,1998,58(8):1730-1732.
5Masciullo V,Ferrandina G,Pucci B,et al.p27kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer:multivariate analysis[J].Clin Cancer Res,2000,6(12):4816-4822.
6Jean A,Hurteau,MD,Bernadette M,et al.Expression and subcelluar localization of the cyclin-dependent kinase inhibitor p27kip1 in epithelial ovarian cancer[J].Gynecologic Oncology,2001,83(2):2982-2987.
7Carrano AC,Eyean E,Hershko A,et al.Sip2 is required for ubiquitin-mdeiated degradation of the CDK inhibitor p27[J].Wat Cell Biot,1999,1(4):193-199.
8Daniel G,Rosen,Gong Y,et al.Subcellular localization of p27 expression predicts poor prognosis in human ovarian cancer[J].Clinican Cancer Research,2005,11(2 pt 1):632-637.
9Li Sui,YouY Dong,Masayuki Ohno,et al.Implication of malignancu and prognosis of p27kip1,cyclinE,and Cdk2 expression in epithelial ovarian tumors[J].Gynecologic Oncology,2001,83(1):56-63.
10Li Sui,Masaaki Tokuda,Masayuki Ohno,et al.The concurrent expression of p27kip1 and CyclinD1 in epithelial ovarian tumors[J].Gynecologic Oncology,1999,73(1):202-209.
